APA Citation

Salvador Bofill, J., Moreno Anton, F., Rodríguez Sánchez, C. A., Galve Calvo, E., Hernando Melia, C., Ciruelos, E., . . . Martin, M. (2022). Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer.

Chicago Style Citation

Salvador Bofill, Javier|||0000-0002-8817-5299, et al. Safety and Efficacy of Ribociclib Plus Letrozole in Patients With HR+, HER2- Advanced Breast Cancer. 2022.

MLA Citation

Salvador Bofill, Javier|||0000-0002-8817-5299, et al. Safety and Efficacy of Ribociclib Plus Letrozole in Patients With HR+, HER2- Advanced Breast Cancer. 2022.

Warning: These citations may not always be 100% accurate.